Benzodiazepine-Associated Hepatic Encephalopathy Significantly Increased Healthcare Utilization and Medical Costs of Chinese Cirrhotic Patients: 7-Year Experience

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Digestive Diseases and Sciences

• Publication date

  2014-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-013-3021-2PMID 24482035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Randomized Clinical Trial

  2013cited by this paper
• Hepatic stellate cells, liver innate immunity, and hepatitis C virus

  2013cited by this paper
• Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients

  2013cited by this paper
• Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2‐Year Longitudinal Clinical Follow‐Up

  2012cited by this paper
• Hepatic encephalopathy: from pathophysiology to therapeutic management

  2011cited by this paper
• Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study.

  2011cited by this paper
• Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.

  2011cited by this paper
• GABAA receptor mutations in epilepsy (Commentary on Lachance‐Touchette et al.)

  2011cited by this paper
• Evidence for epistatic interactions in antiepileptic drug resistance

  2011cited by this paper
• GABA(A) receptor mutations in epilepsy

  2011cited by this paper
• Mechanisms, diagnosis and management of hepatic encephalopathy

  2010cited by this paper
• Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population.

  2010cited by this paper
• Association of the G-protein and α2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial

  2010cited by this paper
• GABAA‐benzodiazepine receptor availability in smokers and nonsmokers: Relationship to subsyndromal anxiety and depression

  2009cited by this paper
• Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad.

  2009cited by this paper
• GABRB2 in Schizophrenia and Bipolar Disorder: Disease Association, Gene Expression and Clinical Correlations

  2009cited by this paper
• GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations.

  2009cited by this paper
• The use of benzodiazepines in the aged patient: clinical and pharmacological considerations.

  2008cited by this paper
• Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy.

  2008cited by this paper
• Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy.

  2008cited by this paper
• Review article: the burden of hepatic encephalopathy

  2007cited by this paper
• Association of GABRG2 polymorphisms with idiopathic generalized epilepsy.

  2007cited by this paper
• Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.

  2006cited by this paper
• Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine

  2003cited by this paper
• Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta‐analysis

  2002cited by this paper
• Structure and subunit composition of GABA(A) receptors.

  1999cited by this paper
• Ammonia and GABA‐ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy

  1997cited by this paper
• Comparison of dose standard units for drug utilisation studies

  1996cited by this paper
• Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy

  1994cited by this paper
• Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

  1991cited by this paper
• mechanism of the excessive sedative response of cirrhotics to benzodiazepines: Model experiments with triazolam

  1987cited by this paper
• Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.

  1986cited by this paper
• Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.

  1984cited by this paper
• Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.

  1983cited by this paper
• Clinical effects and metabolism of diazepam in patients with chronic liver disease.

  1982cited by this paper
• The hepatic coma syndromes and lactulose

  1980cited by this paper
• Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).

  1978cited by this paper
• Intravenous administration of diazepam in patients with chronic liver disease.

  1976cited by this paper
• Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.

  1976cited by this paper
• The effect of cirrhosis on the disposition and elimination of meperidine in man.

  1975cited by this paper
• The effect of cirrhosis on the disposition and elimination of meperidine in man

  1974cited by this paper
• Antidepressants and liver disease

  1972cited by this paper
• Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.

  1972cited by this paper
• Morphine tolerance in hepatic cirrhosis.

  1961cited by this paper

• ACG Clinical Guideline: Hepatic Encephalopathy.

  2026cites this paper
• The Beauty Sleep to Keep a Healthy Liver

  2025cites this paper
• Assessment of microstructural abnormalities in gray and white matter of minimal hepatic encephalopathy patients using diffusion kurtosis imaging and their associations with neurocognitive dysfunction

  2025cites this paper
• Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit

  2025cites this paper
• Depression and anxiety management in cirrhosis

  2024cites this paper
• Palliative care in cirrhosis of the liver

  2024cites this paper
• Opioid use and risks in candidates and recipients of liver transplant

  2024cites this paper
• Quercetin Antagonizes the Sedative Effects of Linalool, Possibly through the GABAergic Interaction Pathway

  2023cites this paper
• Diagnosis and management of hepatic encephalopathy: The French recommendations

  2023cites this paper
• Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis

  2022cites this paper
• A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy

  2021cites this paper
• Diagnosis and Management of Hepatic Encephalopathy

  2021cites this paper
• Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort

  2019cites this paper
• Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

  2018cites this paper
• Pharmacological Considerations in Acute and Chronic Liver Disease

  2018cites this paper
• Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites

  2018cites this paper
• Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in association with zolpidem.

  2017cites this paper
• Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis

  2017cites this paper
• Response to : Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin : hepatic encephalopathy in association with zolpidem

  2017cites this paper